However, there is an established correlation between enhanced androgen-dependence and prostate carcinogenesis and the most striking proof for this is the use of expression of the AR-regulated prostate-specific antigen (PSA) gene as a biologic marker for the diagnosis and treatment of PCa [18,19,20]. This evidence concerns the gene PROS1 and posterior cortical atrophy.